{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:17:22Z","timestamp":1761808642914},"reference-count":11,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,6]]},"DOI":"10.7759\/cureus.50051","type":"journal-article","created":{"date-parts":[[2023,12,6]],"date-time":"2023-12-06T17:40:57Z","timestamp":1701884457000},"source":"Crossref","is-referenced-by-count":3,"title":["An Atypical Presentation of Dulaglutide-Induced Pancreatitis Complicated by Superior Mesenteric Vein Thrombosis"],"prefix":"10.7759","author":[{"given":"Sebastian  L","family":"Manuel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sinan M","family":"Kutty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art","volume":"46","author":"Nauck MA","year":"2021","unstructured":"Nauck MA, Quast DR, Wefers J, Meier JJ. GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art. Mol Metab. 2021, 46:101102. 10.1016\/j.molmet.2020.101102","journal-title":"Mol Metab"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.mcna.2008.04.013","article-title":"Acute pancreatitis: etiology, clinical presentation, diagnosis, and therapy","volume":"92","author":"Cappell MS","year":"2008","unstructured":"Cappell MS. Acute pancreatitis: etiology, clinical presentation, diagnosis, and therapy. Med Clin North Am. 2008, 92:889-923, ix-x. 10.1016\/j.mcna.2008.04.013","journal-title":"Med Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-302779","article-title":"Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus","volume":"62","author":"Banks PA","year":"2013","unstructured":"Banks PA, Bollen TL, Dervenis C, et al.. Classification of acute pancreatitis--2012: revision of the Atlanta classification and definitions by international consensus. Gut. 2013, 62:102-11. 10.1136\/gutjnl-2012-302779","journal-title":"Gut"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2013.2720","article-title":"Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study","volume":"173","author":"Singh S","year":"2013","unstructured":"Singh S, Chang HY, Richards TM, Weiner JP, Clark JM, Segal JB. Glucagonlike peptide 1-based therapies and risk of hospitalization for acute pancreatitis in type 2 diabetes mellitus: a population-based matched case-control study. JAMA Intern Med. 2013, 173:534-9. 10.1001\/jamainternmed.2013.2720","journal-title":"JAMA Intern Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g2366","article-title":"Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies","volume":"348","author":"Li L","year":"2014","unstructured":"Li L, Shen J, Bala MM, et al.. Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies. BMJ. 2014, 348:g2366. 10.1136\/bmj.g2366","journal-title":"BMJ"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f3750","article-title":"Incretins and risk of neoplasia","volume":"346","author":"Halfdanarson TR","year":"2013","unstructured":"Halfdanarson TR, Pannala R. Incretins and risk of neoplasia. BMJ. 2013, 346:f3750. 10.1136\/bmj.f3750","journal-title":"BMJ"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2011.02.018","article-title":"Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies","volume":"141","author":"Elashoff M","year":"2011","unstructured":"Elashoff M, Matveyenko AV, Gier B, Elashoff R, Butler PC. Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies. Gastroenterology. 2011, 141:150-6. 10.1053\/j.gastro.2011.02.018","journal-title":"Gastroenterology"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1111\/jcpt.13225","article-title":"Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes","volume":"45 Suppl 1","author":"Trujillo J","year":"2020","unstructured":"Trujillo J. Safety and tolerability of once-weekly GLP-1 receptor agonists in type 2 diabetes. J Clin Pharm Ther. 2020, 45 Suppl 1:43-60. 10.1111\/jcpt.13225","journal-title":"J Clin Pharm Ther"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2014.03.052","article-title":"Mesenteric venous thrombosis","volume":"4","author":"Hmoud B","year":"2014","unstructured":"Hmoud B, Singal AK, Kamath PS. Mesenteric venous thrombosis. J Clin Exp Hepatol. 2014, 4:257-63. 10.1016\/j.jceh.2014.03.052","journal-title":"J Clin Exp Hepatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra010076","article-title":"Mesenteric venous thrombosis","volume":"345","author":"Kumar S","year":"2001","unstructured":"Kumar S, Sarr MG, Kamath PS. Mesenteric venous thrombosis. N Engl J Med. 2001, 345:1683-8. 10.1056\/NEJMra010076","journal-title":"N Engl J Med"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.7477","article-title":"Isolated thrombosis of the superior mesenteric vein","volume":"12","author":"Essrani R","year":"2020","unstructured":"Essrani R, Mehershahi S, Essrani R, Sudhakaran AM, Mehmood A. Isolated thrombosis of the superior mesenteric vein. Cureus. 2020, 12:e7477. 10.7759\/cureus.7477","journal-title":"Cureus"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/206471-an-atypical-presentation-of-dulaglutide-induced-pancreatitis-complicated-by-superior-mesenteric-vein-thrombosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:21Z","timestamp":1707509361000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/206471-an-atypical-presentation-of-dulaglutide-induced-pancreatitis-complicated-by-superior-mesenteric-vein-thrombosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":11,"URL":"https:\/\/doi.org\/10.7759\/cureus.50051","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,6]]}}}